Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Exploring the Impact of Airway Microbiome on Asthma Morbidity: A Focus on the “Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma—CURE” Project

    The asthma pandemic imposes a huge burden on patients and health systems in both developed and develo** countries. Despite available treatments, symptom control is generally suboptimal, and hospitalizations ...

    Paraskevi Xepapadaki, Spyridon Megremis, Nikoletta Rovina in Pulmonary Therapy (2024)

  2. Article

    Open Access

    Respiratory eukaryotic virome expansion and bacteriophage deficiency characterize childhood asthma

    Asthma development and exacerbation is linked to respiratory virus infections. There is limited information regarding the presence of viruses during non-exacerbation/infection periods. We investigated the naso...

    Spyridon Megremis, Bede Constantinides, Paraskevi Xepapadaki in Scientific Reports (2023)

  3. No Access

    Chapter

    A Current Perspective of Allergic Asthma: From Mechanisms to Management

    Asthma is a result of heterogenous, complex gene–environment interactions with variable clinical phenotypes, inflammation, and remodeling. It affects more than 330 million of people worldwide throughout their ...

    Nikolaos G. Papadopoulos, Michael Miligkos in Allergic Diseases – From Basic Mechanisms … (2022)

  4. Article

    Open Access

    In Vitro Effects of 5-Lipoxygenase Pathway Inhibition on Rhinovirus-Associated Bronchial Epithelial Inflammation

    The leukotriene pathway may be implicated in the induction of virus-induced inflammation. Respiratory epithelial cells may express low levels of 5-lipoxygenase (5-LO) and release leukotrienes (LTs) C4, D4, and...

    Irini Spyridaki, Styliani Taka, Chrysanthi Skevaki in Pulmonary Therapy (2021)

  5. Article

    Open Access

    International severe asthma registry (ISAR): protocol for a global registry

    Severe asthma exerts a disproportionately heavy burden on patients and health care. Due to the heterogeneity of the severe asthma population, many patients need to be evaluated to understand the clinical featu...

    J. Mark FitzGerald, Trung N. Tran, Marianna Alacqua in BMC Medical Research Methodology (2020)

  6. Article

    Open Access

    Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes

    Nasal irrigations (NI) are increasingly used as an over-the-counter adjunctive treatment for allergic rhinitis (AR), but clinical studies on their effectiveness are limited.

    Dimitrios I. Mitsias, Maria V. Dimou in Clinical and Translational Allergy (2020)

  7. Article

    Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”

    Correction to:

    Ludger Klimek, Claus Bachert, Oliver Pfaar, Sven Becker in Allergo Journal International (2020)

  8. Article

    Open Access

    ARIA guideline 2019: treatment of allergic rhinitis in the German health system

    The number of patients affected by allergies is increasing worldwide. The resulting allergic diseases are leading to significant costs for health care and social systems. Integrated care pathways are needed to...

    Ludger Klimek, Claus Bachert, Oliver Pfaar, Sven Becker in Allergo Journal International (2019)

  9. No Access

    Article

    ARIA-Leitlinie 2019: Behandlung der allergischen Rhinitis im deutschen Gesundheitssystem

    Die Anzahl der von Allergien betroffenen Patienten nimmt weltweit zu. Hiermit gehen erhebliche Kosten für die Gesundheits- und Sozialsysteme durch allergische Erkrankungen einher. Integrierte Versorgungskonzep...

    Ludger Klimek, Claus Bachert, Oliver Pfaar, Sven Becker, Thomas Bieber in Allergo Journal (2019)

  10. Article

    Open Access

    Targeted deletion of NFAT-Interacting-Protein-(NIP) 45 resolves experimental asthma by inhibiting Innate Lymphoid Cells group 2 (ILC2)

    Here we investigated the role of NFAT-interacting protein (NIP)-45, an Interleukin (IL)-4 inducing Transcription Factor, and its impact on the differentiation of Group 2 Innate -Lymphoid -Cells (ILC2s) in the ...

    Sonja Koch, Lisa Knipfer, Julia Kölle, Hooman Mirzakhani, Anna Graser in Scientific Reports (2019)

  11. Article

    Open Access

    The safety and tolerability profile of bilastine for chronic urticaria in children

    Urticaria is a condition defined by the development of wheals, angioedema or both. It is classified based on its duration as acute (≤ 6 weeks) or chronic (> 6 weeks). Chronic urticaria is less frequent than ac...

    Nikolaos G. Papadopoulos, Torsten Zuberbier in Clinical and Translational Allergy (2019)

  12. Article

    Open Access

    The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies

    Evidence from observational comparative effectiveness research (CER) is ranked below that from randomized controlled trials in traditional evidence hierarchies. However, asthma observational CER studies repre...

    Jonathan D. Campbell, Robert Perry in Clinical and Translational Allergy (2019)

  13. Article

    Open Access

    Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force

    A Task Force was commissioned jointly by the European Academy of Allergy and Clinical Immunology (EAACI) and the Respiratory Effectiveness Group (REG) to develop a quality assessment tool for real-life observa...

    Nicolas Roche, Jonathan D. Campbell in Clinical and Translational Allergy (2019)

  14. Article

    Open Access

    PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze

    Rhinovirus (RV) infections are major triggers of acute exacerbations of severe respiratory diseases such as pre-school wheeze, asthma and chronic obstructive pulmonary disease (COPD). The occurrence of numerou...

    Katarzyna Niespodziana, Katarina Stenberg-Hammar in Nature Communications (2018)

  15. Article

    Open Access

    The importance of allergic disease in public health: an iCAALL statement

    Mario Sánchez-Borges, Bryan L. Martin in World Allergy Organization Journal (2018)

  16. Article

    Open Access

    Critical view of anaphylaxis epidemiology: open questions and new perspectives

    In contrast to the majority of allergic or hypersensitivity conditions, worldwide anaphylaxis epidemiological data remain sparse with low accuracy, which hampers comparable morbidity statistics. Data can diffe...

    Luciana Kase Tanno, Ana Luiza Bierrenbach in Allergy, Asthma & Clinical Immunology (2018)

  17. Article

    Open Access

    Correction: Corrigendum: IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma

    Scientific Reports 7: Article number: 43426; published online: 06 March 2017; updated: 24 August 2017. This Article contains an error in the Author Information section, where the following statement was omitte...

    Isabella Hentschke, Anna Graser, Volker O. Melichar, Alexander Kiefer in Scientific Reports (2017)

  18. Article

    Open Access

    WAO International Scientific Conference (WISC 2016) Abstracts

    Jun Bao, Yi-Hui Wang, Quan-Hua Liu, Yi-**ao Bao in World Allergy Organization Journal (2017)

  19. Article

    Open Access

    Abstracts from the Food Allergy and Anaphylaxis Meeting 2016

    Guillaume Pouessel, Claire Claverie, Julien Labreuche in Clinical and Translational Allergy (2017)

  20. Article

    Open Access

    IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma

    Here we investigated the relationship between local bacterial colonization and anti-bacterial immune responses in pre-school asthmatic and control children within the EU-wide study PreDicta. In this cohort of ...

    Isabell Hentschke, Anna Graser, Volker O. Melichar, Alexander Kiefer in Scientific Reports (2017)

previous disabled Page of 3